| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |